|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004057,
umls-concept:C0005821,
umls-concept:C0010286,
umls-concept:C0087111,
umls-concept:C0205322,
umls-concept:C0439608,
umls-concept:C0441889,
umls-concept:C0522523,
umls-concept:C1280500,
umls-concept:C1305957,
umls-concept:C1522318,
umls-concept:C1948041
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-5-29
|
|
pubmed:abstractText |
Creatinine kinase-MB (CK-MB) and cardiac troponin I (cTnI) elevations are highly specific for myonecrosis after percutaneous coronary intervention (PCI). Aspirin is used to prevent thrombotic complications. Several studies have shown that some individuals exhibit a reduced or completely missing antiplatelet response to aspirin. The aim of this study is to investigate the effects of platelet reactivity despite aspirin therapy on CK-MB and cTnI levels after elective percutaneous coronary interventions despite 600 mg loading dose of clopidogrel.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0929-5305
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
239-46
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17574519-Aged,
pubmed-meshheading:17574519-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17574519-Aspirin,
pubmed-meshheading:17574519-Biological Markers,
pubmed-meshheading:17574519-Coronary Artery Disease,
pubmed-meshheading:17574519-Creatine Kinase, MB Form,
pubmed-meshheading:17574519-Drug Resistance,
pubmed-meshheading:17574519-Female,
pubmed-meshheading:17574519-Humans,
pubmed-meshheading:17574519-Male,
pubmed-meshheading:17574519-Middle Aged,
pubmed-meshheading:17574519-Myocardium,
pubmed-meshheading:17574519-Necrosis,
pubmed-meshheading:17574519-Platelet Activation,
pubmed-meshheading:17574519-Platelet Aggregation Inhibitors,
pubmed-meshheading:17574519-Platelet Function Tests,
pubmed-meshheading:17574519-Tablets, Enteric-Coated,
pubmed-meshheading:17574519-Thrombosis,
pubmed-meshheading:17574519-Ticlopidine,
pubmed-meshheading:17574519-Time Factors,
pubmed-meshheading:17574519-Troponin I,
pubmed-meshheading:17574519-Up-Regulation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
|
|
pubmed:affiliation |
Department of Cardiology, Baskent University Faculty of Medicine, Ankara, Turkey. gulmezoyku@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
